ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 4.460
+0.120 (2.76%)
At close: Mar 27, 2026
-16.64% (1Y)
| Market Cap | 1.92B -15.8% |
| Revenue (ttm) | 171.70M +94.0% |
| Net Income | -243.24M |
| EPS | -0.59 |
| Shares Out | 431.51M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 750,800 |
| Average Volume | 2,114,320 |
| Open | 4.420 |
| Previous Close | 4.340 |
| Day's Range | 4.410 - 4.640 |
| 52-Week Range | 3.430 - 16.800 |
| Beta | 0.97 |
| RSI | 46.72 |
| Earnings Date | Mar 25, 2026 |